Humira set to face new European biosimilar rival
June 26, 2017Sales and Marketing CHMP, EMA, Samsung Bioepis
A position opinion from the EMA for Samsung Bioepis’ biosimilar of Humira looks set to unleash a second rival to …
Roche haemophilia therapy cuts bleed rate by 87%
June 26, 2017Research and Development, Sales and Marketing Roche, haemophilia
Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …
Public dissatisfaction with NHS found to be growing, says BMA
June 26, 2017Medical Communications, Sales and Marketing BMA, NHS
The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …
Promising Phase 2 obesity data for Novo’s diabetes drug
June 26, 2017Research and Development, Sales and Marketing Novo Nordisk
Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …
Astellas receives further year suspension from ABPI
June 26, 2017Medical Communications, Sales and Marketing ABPI, Astellas
The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …
Woodley Equipment Attending Outsourcing in Clinical Trials UK & Ireland 2017
June 23, 2017Woodley Equipment is attending Outsourcing in Clinical Trials UK and Ireland Conference taking place at the Royal Garden Hotel, London …
Pfizer’s biosimilar gets a second knock-back from FDA
June 23, 2017Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer
Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …
Novartis lung cancer combo receives FDA approval
June 23, 2017Medical Communications, Sales and Marketing NSCLC, Novartis
Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …
HIV cases in gay men fall for the first time in England
June 23, 2017Medical Communications HIV, PrEP
For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …
Rare cancers through the looking glass
June 23, 2017Medical Communications, Research and Development pharmafile, rare cancer
Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …
Top Ten most popular articles on Pharmafile.com this week
June 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …
Immune system attacks the brain in Alzheimer’s, study suggests
June 22, 2017Research and Development Alzheimer's
New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a …
Risk estimate produced from long-term BRCA gene study
June 22, 2017Research and Development BRCA, Cancer Research UK, University of Cambridge
A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages …
New research unlocks the key to slowing cancer metastasis
June 22, 2017Research and Development Cancer, metastasis
Stemming from a theory she developed as a sophomore at John Hopkins University in Maryland, Hasini Jayatilaka and a team …
Novartis pulls off surprise success in cardiovascular risk
June 22, 2017Research and Development, Sales and Marketing Novartis
Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …
FDA’s Gottlieb draws those ‘gaming’ system into pricing debate
June 22, 2017Medical Communications, Sales and Marketing Drug pricing, FDA, Trump
President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …
FDA locks down import from 3 Indian IPCA facilities
June 21, 2017Manufacturing and Production, Research and Development FDA, India, Ipca
More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of …
10 years later, Shire gains FDA approval for ADHD drug
June 21, 2017Research and Development, Sales and Marketing ADHD, Shire
Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …
Immune system exhaustion associated with irritable bowel syndrome
June 21, 2017Research and Development IBS, irritable bowel syndrome, t cells
Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …
FDA backs Novo’s diabetes drug for cardiovascular efficacy
June 21, 2017Research and Development Novo Nordisk, Victoza
Good news for Novo Nordisk as the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommends that data …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
